. 2003 Nov;77(21):11733–11744. doi: 10.1128/JVI.77.21.11733-11744.2003

TABLE 1.

DC recovery from peripheral lymph nodes of CD4C/HIV^MutA transgenic mice

Expt no.	Mouse age (mo)	No. of mice^a	Nontransgenic				Transgenic
			Total no. (10⁵)	% of DC			Total no. (10⁵)	% of DC
			Total no. (10⁵)	CD11b^neg-int	CD11b^hi	CD8α⁺	Total no. (10⁵)	CD11b^neg-int	CD11b^hi	CD8α⁺
1	1.5	2	1.3	81	15	35	3.0	75	21	20
2	2	2	0.7	69	29	25	0.7	65	35	16
3	2	2	0.8	65	29	25	0.8	60	39	24
4	2	4	1.4	66	34	ND	0.8	59	41	ND
5	2.5	2	0.5	49	48	ND	0.5	38	60	ND
6	2.5	2	1.5	58	16	22	0.7	50	16	9
1 to 6	1.5-2.5	14	1.0 ± 0.2	65 ± 4	28 ± 5	27 ± 3	1.0 ± 0.4	58 ± 5*	35 ± 6**	17 ± 3
7	3	3	0.6	68	32	ND	0.3	45	55	ND
8	3	2	1.4	69	29	ND	0.5	24	75	ND
9	3	4	2.2	37	64	ND	1.0	22	79	ND
10	3	2	3.0	72	27	23	2.4	68	31	17
11	3.5	3	1.3	83	17	ND	1.5	72	28	ND
12	4	2	1.2	60	34	ND	1.0	46	50	ND
13	4	3	0.6	71	29	10	0.5	46	54	6
14	5.5	2	1.7	74	23	ND	1.0	53	46	ND
7 to 14	3-5.5	21	1.5 ± 0.3	67 ± 5	32 ± 5	17 ± 7	1.0 ± 0.2	47 ± 6*	52 ± 6**	12 ± 6

The number indicated applies to both nontransgenic and transgenic mice (i.e., 2 indicates two of each). Total, data represent absolute numbers of DC recovered per mouse. CD11b levels of expression appear as high (CD11b^Hi) or negative to intermediate (CD11b^neg-int). The data are presented as mean ± standard error of the mean. ND, not done. Each experiment was done with sex-matched littermate controls. *, P = 0.023, **, P = 0.03 (two-way analysis of variance).